New research shows patients with Parkinson's disease were more willing to help others after taking their dopamine-boosting ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

In one of the largest studies of its kind, researchers found that increasing dopamine levels with L-DOPA made people slightly ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and decision-making in humans so far, providing evidence for effects of the former on the ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

A video intended to be watched for just a moment before sleep extends until dawn. Despite vowing to abstain from alcohol, one ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...